PET/MRI scan to help plan surgery for hyperinsulinism
Part of Cancer, Digestive system, Genetic & congenital, Hormones & metabolism clinical trials.
This Phase 2 study uses special PET/MRI imaging to better understand a cause of hyperinsulinemic low blood sugar and guide whether surgery may help. It may help doctors choose the safest plan to reduce severe episodes and protect the brain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with hyperinsulinemic hypoglycemia (low blood sugar caused by too much insulin).
- You have tried medicines like diazoxide or octreotide, and they did not work.
- Your endocrinologist believes standard care can’t safely control your condition and recommends surgery to prevent severe episodes and protect brain function.
- You (if able) or a parent/legal guardian can sign informed consent to take part.
- You can safely undergo MRI; if MRI isn’t safe for you, the study may use a PET/CT scan instead.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special PET scan to measure how well insulin-producing cells (“beta cells”) in the pancreas are working in people with diabetes. It’s meant to help researchers understand diabetes biology and test whether the scan can reflect beta cell function.
This Phase 2 study uses an FDOPA PET scan to find where insulin overproduction is coming from in focal congenital hyperinsulinism (FoHI) or related conditions. The goal is to help doctors better detect and localize the “source” so treatment can be more targeted.
This Phase 1 study tests a special imaging medicine (fluorodopa F 18) to help doctors better understand congenital hyperinsulinism (HI) patterns in the body. It may help guide treatment decisions to prevent dangerous low blood sugar and protect brain function.
This trial improves a special PET scan (a type of brain/body imaging) using 18F-DOPA, to better show how certain conditions behave in the body. If you or your child may have one of the listed conditions, the study may help your doctors get clearer scan results.
This study tests a new type of PET/MRI scan that uses a special tracer (18F-FET) to better find small pituitary tumors that didn't show up on a standard MRI. The goal is to help guide surgery to remove the tumor.
This trial uses a special type of PET scan (18FET PET) to help find active pituitary tumors when standard MRI images are not clear. This could help doctors decide the best next step, like surgery or radiation, for people with certain hormone-producing tumors.
Hear when a new Hyperinsulinism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.